3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Withdrawn
2
Completed
2
Terminated
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
2
Conditions
Carcinoma, Renal Cell
24
Kidney Neoplasms
10
Neoplasms
9
Carcinoma
6
Colorectal Neoplasms
5
Carcinoma, Hepatocellular
5
Carcinoma, Non-Small-Cell Lung
4
Recurrence
3
Neoplasm Metastasis
3
Melanoma
3
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Lung Neoplasms
2
Kidney Diseases
2
Glioblastoma
2
Carcinoma, Adenoid Cystic
2
Breast Neoplasms
2
Advanced Solid Tumors
2
cT2a N0NxM0 Renal Tumor
1
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Solitary Fibrous Tumors
1
Solid Tumors
1
Solid Malignancies
1
Skin Neoplasms
1
Sarcoma, Alveolar Soft Part
1
Salivary Gland Neoplasms
1
Refractory or Recurrent Solid Tumors, Excluding CNS Tumors
1
Prostatic Neoplasms
1
Interventions
Temozolomide
203
Radiotherapy
118
Bevacizumab
93
Radiation
40
Magnetic Resonance Spectroscopy
28
Irinotecan
27
Carmustine
25
Surgical Procedures, Operative
24
Lomustine
21
Erlotinib Hydrochloride
19
Chemotherapy, Adjuvant
18
Carboplatin
17
temsirolimus
13
Drug Therapy
13
O(6)-benzylguanine
12
Nivolumab
12
sargramostim
11
Sirolimus
11
Radiotherapy, Intensity-Modulated
11
Radiotherapy, Conformal
11
Sorafenib
10
Radiosurgery
10
Imatinib Mesylate
10
Everolimus
10
pembrolizumab
9
motexafin gadolinium
9
Vorinostat
9
Thalidomide
8
IL13-PE38
8
Gefitinib
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Glioblastoma
×
Axitinib
×
Clear all
NCT01562197
2019-01-24
AxiGII
Universitair Ziekenhuis Brussel
Phase 2
Completed
56 enrolled
NCT03291314
2019-01-23
GliAvAx
Universitair Ziekenhuis Brussel
Phase 2
Completed
52 enrolled